Isatuximab in Type I Cryoglobulinemia

NCT05114109 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Monoclonal Gammopathy of Undetermined Significance
Cryoglobulinemic Vasculitis

Interventions

DRUG: Isatuximab Injection

Sponsor

Assistance Publique - Hôpitaux de Paris